中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2012年
18期
2739-2741
,共3页
胎膜早破%宫颈Bishop评分%地诺前列醇栓
胎膜早破%宮頸Bishop評分%地諾前列醇栓
태막조파%궁경Bishop평분%지낙전렬순전
Fetal membranes premature rupture%Cervical bishop score%Dinoprestone
目的 探讨地诺前列醇栓用于足月胎膜早破促进宫颈成熟的临床疗效.方法 对42例足月胎膜早破孕妇随机分为地诺前列醇栓组及缩宫素组各21例,地诺前列醇栓组采取地诺前列醇栓阴道后穹窿放药引产,缩宫素组静脉滴注缩宫索引产,观察两组引产所需时间、用药后6h、12 h宫颈Bishop评分、药物起效时间、产程情况及其围产儿情况、妊娠结局等指标.结果 地诺前列醇栓组用药到临产时间、用药到宫颈口开全时间分别为(6.18±4.48)h、( 12.62±8.03)h,短于缩宫素组的(10.21±5.42)h、(18.87±9.14)h(t=2.62、2.35,均P<0.05);用药后6h、12 h地诺前列醇栓组评分为(7.52±2.44)分、(9.03±1.96)分,优于缩宫素组的(5.97±1.95)分、(7.13±2.12)分(t=2.27、3.02,均P<0.05);地诺前列醇栓组潜伏期平均(9.91±1.73)h大于缩宫素组(8.72±1.34)h,活跃期(4.36±0.66)h小于缩宫素组(5.84±1.02)h,两组差异均有统计学意义(t =2.49、5.58,均P<0.05);两组第二产程时间、第三产程时间、胎儿宫内窘迫、羊水污染、剖宫产、新生儿Apgar评分等差异均无统计学意义(均P>0.05).结论 地诺前列醇栓用于足月胎膜早破孕妇可促进宫颈成熟,效果优于缩宫素,且用药安全性较高.
目的 探討地諾前列醇栓用于足月胎膜早破促進宮頸成熟的臨床療效.方法 對42例足月胎膜早破孕婦隨機分為地諾前列醇栓組及縮宮素組各21例,地諾前列醇栓組採取地諾前列醇栓陰道後穹窿放藥引產,縮宮素組靜脈滴註縮宮索引產,觀察兩組引產所需時間、用藥後6h、12 h宮頸Bishop評分、藥物起效時間、產程情況及其圍產兒情況、妊娠結跼等指標.結果 地諾前列醇栓組用藥到臨產時間、用藥到宮頸口開全時間分彆為(6.18±4.48)h、( 12.62±8.03)h,短于縮宮素組的(10.21±5.42)h、(18.87±9.14)h(t=2.62、2.35,均P<0.05);用藥後6h、12 h地諾前列醇栓組評分為(7.52±2.44)分、(9.03±1.96)分,優于縮宮素組的(5.97±1.95)分、(7.13±2.12)分(t=2.27、3.02,均P<0.05);地諾前列醇栓組潛伏期平均(9.91±1.73)h大于縮宮素組(8.72±1.34)h,活躍期(4.36±0.66)h小于縮宮素組(5.84±1.02)h,兩組差異均有統計學意義(t =2.49、5.58,均P<0.05);兩組第二產程時間、第三產程時間、胎兒宮內窘迫、羊水汙染、剖宮產、新生兒Apgar評分等差異均無統計學意義(均P>0.05).結論 地諾前列醇栓用于足月胎膜早破孕婦可促進宮頸成熟,效果優于縮宮素,且用藥安全性較高.
목적 탐토지낙전렬순전용우족월태막조파촉진궁경성숙적림상료효.방법 대42례족월태막조파잉부수궤분위지낙전렬순전조급축궁소조각21례,지낙전렬순전조채취지낙전렬순전음도후궁륭방약인산,축궁소조정맥적주축궁색인산,관찰량조인산소수시간、용약후6h、12 h궁경Bishop평분、약물기효시간、산정정황급기위산인정황、임신결국등지표.결과 지낙전렬순전조용약도임산시간、용약도궁경구개전시간분별위(6.18±4.48)h、( 12.62±8.03)h,단우축궁소조적(10.21±5.42)h、(18.87±9.14)h(t=2.62、2.35,균P<0.05);용약후6h、12 h지낙전렬순전조평분위(7.52±2.44)분、(9.03±1.96)분,우우축궁소조적(5.97±1.95)분、(7.13±2.12)분(t=2.27、3.02,균P<0.05);지낙전렬순전조잠복기평균(9.91±1.73)h대우축궁소조(8.72±1.34)h,활약기(4.36±0.66)h소우축궁소조(5.84±1.02)h,량조차이균유통계학의의(t =2.49、5.58,균P<0.05);량조제이산정시간、제삼산정시간、태인궁내군박、양수오염、부궁산、신생인Apgar평분등차이균무통계학의의(균P>0.05).결론 지낙전렬순전용우족월태막조파잉부가촉진궁경성숙,효과우우축궁소,차용약안전성교고.
Objective To explore clinical effect of dinoprostone in premature rupture of the membranes at term cervical ripening.Methods 42 cases with premature rupture of the membranes at term cervical ripening were selected.All patients were randomly divided into two groups.The dinoprostone group had 21 cases,which applied the treatment of dinoprostone belt the posterior fornix of vagina medicine induced abortion.The oxytocin group had 21 cases,which applied the treatment of intravenous drip oxytocin.The time of induction labor,6h,12h cervical Bishop score after using the medication,drugs acting time,labor conditions and perinatal situation,pregnancy outcome and some other index were observed.Results It taken (6.18 ± 4.48 ) h until parturient and ( 12.62 ± 8.03 ) h until the cervical mouth full open in the dinoprostone group,which were shorter than the oxytocin group,that taken( 10.21 ±5.42) h,( 18.87 ± 9.14) h.( t =2.62,2.35,all P < 0.05 ).There was no significant difference about cervical Bishop score before using the medication.It's(7.52 ± 2.44 ) point 6h after using the medication and( 9.03 ± 1.96 ) point 12h after in the dinoprostone group.They were better than the oxytocin group,which were(5.97 ± 1.95 )point,(7.13 ±2.12 )point.It was significantly different( t =2.27,3.02,all P <0.05 ).The average incubation period of dinoprostone group wss (9.91 ± 1.73 )h.It's longger than the oxytocin group,which was( 8.72 ± 1.34)h.The active period of dinoprostone group was(4.36 ± 0.66 ) h.It's shortter than the oxytocin group,which was( 5.84 ± 1.02 ) h.The difference was significant( t =2.49,5.58,all P < 0.05 ).There was no significant difference in the second and third stage of laber between the two groups( t =0.56,0.33,all P > 0.05 ).There was also no significant difference about intrauterine distress,amniotic fluid contamination,cesarean section,intestinal bleeding,the Apgar score of newborns and some other index in the two groups ( x2 =0.00,0.00,0.52,t =0.84,1.04,all P > 0.05 ).Conclusion Dinoprostone had good promoting effect on cervical ripening for preterm premature rupture of membranes pregnant woman.Its effect was better than oxytocin and it was safe to use.